Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR)

Anne Godier; Pierre Fontana; Serge Motte; Annick Steib; Fanny Bonhomme; Sylvie Schlumberger; Thomas Lecompte; Nadia Rosencher; Sophie Susen; André Vincentelli; Yves Gruel; Pierre Albaladejo; Jean-Philippe Collet; French Working Group on perioperative hemostasis (GIHP)

doi:10.1016/j.acvd.2017.12.004

Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR)

Arch Cardiovasc Dis. 2018 Mar;111(3):210-223. doi: 10.1016/j.acvd.2017.12.004. Epub 2018 Feb 3.

Collaborators

French Working Group on perioperative hemostasis (GIHP):
P Albaladejo¹⁴, S Belisle¹⁵, N Blais¹⁶, F Bonhomme¹⁷, A Borel-Derlon¹⁸, J Y Borg¹⁹, J-L Bosson²⁰, A Cohen²¹, J-P Collet²¹, E de Maistre²², D Faraoni²³, P Fontana²⁴, D Garrigue Huet²⁵, A Godier²⁶, Y Gruel²⁷, J Guay¹⁵, J F Hardy¹⁵, Y Huet²¹, B Ickx²⁸, S Laporte²⁹, D Lasne³⁰, J H Levy³¹, J Llau³², G Le Gal³³, T Lecompte³⁴, S Lessire³⁵, D Longrois²⁶, S Madi-Jebara³⁶, E Marret²⁶, J L Mas³⁷, M Mazighi³⁷, P Mismetti³⁸, P E Morange³⁹, S Motte⁴⁰, F Mullier⁴¹, N Nathan⁴², P Nguyen⁴³, Y Ozier⁴⁴, G Pernod²⁰, N Rosencher²⁶, S Roullet⁴⁵, P M Roy⁴⁶, C M Samama²⁶, S Schlumberger⁴⁷, J F Schved⁴⁸, P Sié⁴⁹, A Steib⁵⁰, S Susen⁵¹, E van Belle⁵², P van Der Linden²⁸, A Vincentelli⁵³, P Zufferey⁵⁴

Affiliations

¹ Department of Anesthesiology and Intensive Care, Fondation Rothschild, INSERM UMR-S1140, Paris Descartes university, Paris, France. Electronic address: [email protected].
² Division of angiology and haemostasis and Geneva Platelet Group, University hospitals of Geneva, Geneva, Switzerland.
³ Department of Vascular Diseases, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
⁴ Department of Anesthesiology and Intensive Care, NHC, University Hospital-Federation de Medecine Translationnelle, Strasbourg, France.
⁵ Department of Anesthesiology, Pharmacology, and Intensive Care, Geneva University Hospitals, Geneva, Switzerland.
⁶ Department of Anesthesiology, Foch Hospital, Suresnes, France.
⁷ Department of Medical Specialties, Geneva University Hospitals and Geneva Platelet Group (GpG), Faculty of Medicine, University of Geneva, Geneva, Switzerland.
⁸ Cochin Hospital (AP-HP), Paris Descartes University, Paris, France.
⁹ Institut d'hématologie-transfusion, University Lille, Inserm, CHU Lille, U1011 - EGID, 59000 Lille, France.
¹⁰ Department of cardiac surgery, centre hospitalier régional universitaire de Lille, Lille, France.
¹¹ Department of Hematology-Hemostasis. University-Hospital of Tours, 37044 Tours cedex, France.
¹² Department of Anesthesiology and Critical Care, Grenoble Alpes University Hospital, Grenoble ThEMAS, TIMC, UMR CNRS 5525, Université Grenoble-Alpes, Grenoble, France.
¹³ Département de cardiologie, Sorbonne Universités_Univ Paris 06 (UPMC), ACTION Study Group, Inserm UMR_S 1166, institut de cardiologie, Pitié-Salpêtrière Hospital (AP-HP), Paris, France.
¹⁴ Anesthésie-réanimation, Grenoble, France.
¹⁵ Anesthésie, Montréal, Canada.
¹⁶ Hématologie-hémostase, Montréal, Canada.
¹⁷ Anesthésie-réanimation, Genève, Suisse.
¹⁸ Hématologie-hémostase, Caen, France.
¹⁹ Hémostase, Rouen, France.
²⁰ Médecine vasculaire, Grenoble, France.
²¹ Cardiologie, Paris, France.
²² Hématologie, Dijon, France.
²³ Anesthésie-réanimation, Toronto, Canada.
²⁴ Hémostase, Genève, Suisse.
²⁵ Anesthésie-réanimation, Lille, France.
²⁶ Anesthésie-réanimation, Paris, France.
²⁷ Hématologie, Tours, France.
²⁸ Anesthésie-réanimation, Bruxelles, Belgique.
²⁹ Pharmacologie, Saint-Etienne, France.
³⁰ Hématologie, Paris, France.
³¹ Anesthésie-réanimation, Durham, USA.
³² Anesthésie, Valence, Espagne.
³³ Médecine vasculaire, Ottawa, Canada.
³⁴ Hématologie, Genève, Suisse.
³⁵ Anesthésie, Namur, Belgique.
³⁶ Anesthésie, Beyrouth, Liban.
³⁷ Neurologie, Paris, France.
³⁸ Pharmacologie clinique, Saint-Etienne, France.
³⁹ Hématologie, Marseille, France.
⁴⁰ Pathologie vasculaire, Bruxelles, Belgique.
⁴¹ Hématologie, Namur, Belgique.
⁴² Anesthésie-réanimation, Limoges, France.
⁴³ Hématologie, Reims, France.
⁴⁴ Anesthésie-réanimation, Brest, France.
⁴⁵ Anesthésie réanimation, Bordeaux, France.
⁴⁶ Médecine d'urgence, Angers, France.
⁴⁷ Anesthésie-réanimation, Suresnes, France.
⁴⁸ Hématologie, Montpellier, France.
⁴⁹ Hématologie, Toulouse, France.
⁵⁰ Anesthésie-réanimation, Strasbourg, France.
⁵¹ Hématologie Transfusion, Lille, France.
⁵² Cardiologie, Lille, France.
⁵³ Chirurgie cardiaque, Lille, France.
⁵⁴ Anesthésie-réanimation, Saint-Etienne, France.

PMID: 29402671
DOI: 10.1016/j.acvd.2017.12.004

No abstract available

Keywords: Agent antiplaquettaire; Anesthésie loco-régionale; Antiplatelet therapy; Chirurgie; Haemorrhage; Hémorragie; Local anaesthesia; Surgery; Thrombose; Thrombosis.

Publication types

Practice Guideline
Review

MeSH terms

Blood Loss, Surgical / prevention & control*
Consensus
Drug Administration Schedule
Elective Surgical Procedures* / adverse effects
France
Hemostasis / drug effects*
Humans
Platelet Aggregation Inhibitors / administration & dosage*
Platelet Aggregation Inhibitors / adverse effects
Postoperative Hemorrhage / chemically induced
Postoperative Hemorrhage / prevention & control*
Risk Factors
Thrombosis / blood
Thrombosis / prevention & control*
Treatment Outcome

Substances

Platelet Aggregation Inhibitors